Global Insulin Drug and Delivery Technologies Market by Type (Insulin Syringes, Insulin Vials, Insulin Pens, Insulin Pumps), By Application (Diabetes Mellitus Type 1, Diabetes Mellitus Type 2, Gestational Diabetes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

                                          

                                                                                       
Market Overview:

The global insulin drug and delivery technologies market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin delivery devices, and rising awareness about diabetes management. The global insulin drug and delivery technologies market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into insulin syringes, insulin vials, insulin pens, and insulin pumps. The Insulin Syringes segment is expected to account for the largest share of the global market in 2018 owing to their low cost and easy availability. However, with technological advancements being made in other segments such as Insulin Pens and Insulin Pumps segments; these segments are projected to grow at a higher CAGR during the forecast period.



Get Free Sample Report

Product Definition:

Insulin Drug and Delivery Technologies are a group of technologies used to deliver insulin to the body. This includes delivery methods such as injections, pumps, and inhalers. These technologies are important because they allow people with diabetes to manage their blood sugar levels.

Insulin Syringes:

Insulin syringes are used to deliver insulin into a patient's body. Insulin syringes have been in use for almost 80 years and were developed by the American physician, Dr. John Collins (1906-1975). The modern insulin pen was introduced in the early 2000s and has since taken over from traditional syringes due to its many advantages such as portability, less risk of disease transmission etc.

Insulin Vials:

Insulin vials are small containers that contain insulin. They come in different sizes and can be used with various drug delivery technologies. Insulin vials are most commonly used with pen devices, however they can also be used with syringes or jet injectors.

Application Insights:

The diabetes mellitus type 2 segment held the largest revenue share in 2017. This is because of the increasing prevalence of diabetes and its associated complications, such as cardiovascular diseases, nephrological disorders and neuropathy. According to a study conducted by the CDC in 2016, around 41% of adults aged 65 years or above have prediabetes symptoms which indicate that they are at risk for developing full blown diabetes during this time. Thus, growing incidence rate for type 2 diabetes coupled with advanced therapies available for managing this condition is expected to drive demand over the forecast period.

On the other hand, insulin pumps are estimated to witness lucrative CAGR owing to rising awareness about lifestyle management among individuals suffering from type 1 and other pre-diabetic conditions along with technological advancements that enhance patient compliance levels while reducing healthcare costs involved in pump therapy administration. Furthermore, ongoing research pertaining to new device designs as well as innovations introduced in existing products is anticipated to further boost industry growth over the coming years.

Regional Analysis:

North America dominated the global insulin drug and delivery technologies market in 2017. This can be attributed to the presence of major players, high disposable income, better healthcare facilities & infrastructure along with a higher adoption rate of advanced medical products. Moreover, government support for R&D activities is another factor boosting this regional market growth. For instance, in December 2016; The Diabetes Research Foundation (DRF) awarded Novo Nordisk a research grant of USD X million for diabetes prevention through lifestyle modification program initiated by its scientists at University of California Los Angeles (UCLA).

Asia Pacific region is expected to witness lucrative growth over the forecast period owing to increasing cases of type 1 diabetes and other factors such as aging population and unhealthy lifestyles leading to obesity which are further fueling up an increase in cases related health issues such as heart diseases & stroke along with kidney & eye problems that require long term treatment using insulin syringes/vials/pens/pumps or other similar devices.

Growth Factors:

Increasing incidence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for insulin drugs and delivery technologies.
Technological advancements: The insulin drug and delivery technology market is witnessing rapid technological advancements, with new products being launched regularly. This has helped to improve the quality of life for people living with diabetes mellitus.
Growing awareness about diabetes: There has been a growing awareness about diabetes in recent years, thanks to various campaigns by healthcare organizations and governments around the world. This has led to an increase in demand for insulin drugs and delivery technologies among people suffering from this disease condition..


Get Free Sample Report
Scope Of The Report
Report Attributes
Report Details
Report Title
Insulin Drug and Delivery Technologies Market Research Report
By Type
Insulin Syringes, Insulin Vials, Insulin Pens, Insulin Pumps
By Application
Diabetes Mellitus Type 1, Diabetes Mellitus Type 2, Gestational Diabetes
By Companies
Sanofi, Eli Lilly and Company, Biocon, Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.

Global Insulin Drug and Delivery Technologies Market Report Segments:
The global Insulin Drug and Delivery Technologies market is segmented on the basis of:
Types
Insulin Syringes, Insulin Vials, Insulin Pens, Insulin Pumps
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes Mellitus Type 1, Diabetes Mellitus Type 2, Gestational Diabetes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Sanofi



Get Free Sample Report

Highlights of The Insulin Drug and Delivery Technologies Market Report:
The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of market.
Historical data and forecast.
Estimations for the forecast period 2030.
Developments and trends in the market.
By Type:
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
By Application:
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Insulin Drug and Delivery Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals



8 Reasons to Buy This Report
Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Frequently Asked Questions?